Trinity Biotech PLC（TRIB）價格預測TRIBTrinity Biotech PLC

Alphio's TRIB stock price prediction model matches the current Trinity Biotech PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.04 (-0.55%). The 1-week path is $6.03 (-0.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Trinity Biotech PLC (TRIB) is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $6.07, and the stock has a very low RSI of 23.25, indicating it is oversold. Furthermore, the forward P/E ratio is 4.54, which might seem attractive, but the company has a negative net income of -$4.39 million in Q1 2026 and a gross margin of only 35.43%. The main risk is the company's failure to regain Nasdaq compliance, which could further depress the stock price.

Trinity Biotech PLC (TRIB) last closed at $6.0700002, gaining +2.97%. These facts feed the 1-day and 1-week TRIB price prediction above.